Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
12/2009
12/03/2009WO2009090651A3 Major histocompatibility complex hla-b2705 ligands useful for therapy and diagnosis
12/03/2009WO2009081170A3 Peptide fusion proteins
12/03/2009WO2009075838A3 Treatment of menorrhagia with aromatase inhibitor
12/03/2009WO2009043479A3 Use of eaa-mart1 (26-35) for the treatment of human cytomegalovirus infections
12/03/2009WO2009043478A3 Use of bubuc and optionally eaa-mart1 (26-35) as a therapeutic agent for the treatment of hcmv infections
12/03/2009WO2009039310A3 Light inhibitors for asthma, lung and airway inflammation, respiratory, interstitial, pulmonary and fibrotic disease treatment
12/03/2009WO2009014615A3 Amphipathic alpha-helical peptide compositions as antiviral agents
12/03/2009WO2008093165A3 The use of pgil ohgosaccharyltransferase for o-glycosylating proteins
12/03/2009WO2004018646A9 Conserved and specific streptococcal genomes
12/03/2009US20090300778 Neutral Sphingomyelinase-E and Its Use
12/03/2009US20090300776 Compositions for preventing, reducing or treating keratinocyte-mediated inflammation
12/03/2009US20090299190 Ultrasound Molecular Sensors and Uses Thereof
12/03/2009US20090299127 Magnet-Field Controlled Active Substance Transfer for Aerosol Therapy
12/03/2009US20090299050 Multi-Arm Block Copolymers as Drug Delivery Vehicles
12/03/2009US20090298921 Methods and compositions for use in homologous recombination
12/03/2009US20090298849 Materials and Methods Relating to the Induction of Apoptosis in Target Cells
12/03/2009US20090298782 Compounds for Delivering Amino Acids or Peptides with Antioxidant Activity into Mitochondria and Use Thereof
12/03/2009US20090298781 Compounds for the inhibition of apoptosis
12/03/2009US20090298780 Methods To Produce Lung Surfactant Formulations Via Lyophilization And Formulations And Uses Thereof
12/03/2009US20090298779 Peptides which Modulate Blood Coagulation and Methods of Use Thereof
12/03/2009US20090298778 Peptides Modulating the Activity of Macrophages, Useable for the Treatment of Rheumatoid Arthritis
12/03/2009US20090298777 Spinal fusion methods and devices
12/03/2009US20090298776 Spinal fusion methods and devices
12/03/2009US20090298775 Method of measuring neprilysin activity
12/03/2009US20090298774 Bifunctional Molecules for Inhibiting HIV Entry
12/03/2009US20090298773 Methods of producing functional miso
12/03/2009US20090298772 Therapeutics to inhibit mll-menin interaction for treating leukemia
12/03/2009US20090298771 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
12/03/2009US20090298770 Mammalian relaxin receptors
12/03/2009US20090298769 Compounds and methods of modulating angiogenesis
12/03/2009US20090298768 Stable liquid formulation of human growth hormone
12/03/2009US20090298767 Formulation comprising whey protein and hydrolysates for improving muscle recovery
12/03/2009US20090298766 Detection and treatment of cancers
12/03/2009US20090298765 Metastin derivatives and use thereof
12/03/2009US20090298764 Gene and pathway and their use in methods and compositions for predicting onset or progression of autoimmune and/or autoinflammatory diseases
12/03/2009US20090298763 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
12/03/2009US20090298762 Conjugates of biologically active proteins having a modified in vivo half-life
12/03/2009US20090298761 Methods of treating cartilage defects using a soluble morphogenic protein complex
12/03/2009US20090298760 Modified Coagulation Factor VIIa With Extended Half-Life
12/03/2009US20090298759 C-Reactive Protein and Its Use to Treat Systemic Lupus Erythematosus and Related Conditions
12/03/2009US20090298758 Thymosin beta 4 derivatives and use thereof
12/03/2009US20090298757 Oxyntomodulin analogues and their effects on feeding behaviour
12/03/2009US20090298756 Functions and uses of gpr39 gene in mammalian central nervous system
12/03/2009US20090298755 Novel Chimeric Analgesic Peptides
12/03/2009US20090298754 Hai-1 and hai-2 in cancer therapy
12/03/2009US20090298753 Methods for the therapeutic use of cyclosporine components
12/03/2009US20090298752 Aplidine treatment of cancers
12/03/2009US20090298751 Arylalkyl and Heteroarylalkyl Derivaties of Cyclosporine a for the Treatment and Prevention of Viral Infection
12/03/2009US20090298750 Daptomycin for the treatment of biofilm and catheter salvage
12/03/2009US20090298749 Dalbavancin compositions for treatment of bacterial infections
12/03/2009US20090298748 Methods of administering dalbavancin for treatment of bacterial infections
12/03/2009US20090298747 Methods and Compositions For Treatment of Nitric Oxide-Induced Clinical Conditions
12/03/2009US20090298746 Pegylated hemoglobin and albumin and uses thereof
12/03/2009US20090298745 Treatment of Diabetes with Glycogen Phosphorylase Inhibitors
12/03/2009US20090298744 Heterocyclic compounds as adenosine receptor antagonist
12/03/2009US20090298743 Hydrophobic compositions containing reconstitution enhancer
12/03/2009US20090298742 Process for manufacturing lactose
12/03/2009US20090298741 Trophic Factor Combinations for Nervous System Treatment
12/03/2009US20090298740 Novel nucleotide sequences
12/03/2009US20090298711 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects
12/03/2009US20090298156 Thymidine Kinase Mutants and Fusion Proteins Having Thymidine Kinase and Guanylate Kinase Activities
12/03/2009US20090298123 Novel Lipase Genes
12/03/2009US20090298099 Gonococcal Proteins and Nucleic Acids
12/03/2009US20090297619 Nanoparticulate anticonvulsant and immunosuppressive compositions
12/03/2009US20090297609 Method of Biomolecule Immobilization On Polymers Using Click-Type Chemistry
12/03/2009US20090297607 Biomimetic polymers and uses thereof
12/03/2009US20090297605 Composition And Device For In Vivo Cartilage Repair
12/03/2009US20090297592 Lipid Vesicle Composition
12/03/2009US20090297588 Antibiotic dressing for the treatment of infected wounds
12/03/2009US20090297580 Spinal nucleus pulposus implant
12/03/2009US20090297577 Local Delivery of Apolipoproteins and Their Derivatives
12/03/2009US20090297573 Identifying and Modulating Molecular Pathways that Mediate Nervous System Plasticity
12/03/2009US20090297559 Use of tight junction agonists to facilitate pulmonary delivery of therapeutic agents
12/03/2009US20090297547 Pharmaceutical composition containing the nmb0938 protein
12/03/2009US20090297545 Immunomodulatory dairy peptides and uses thereof
12/03/2009US20090297544 Novel tumor antigen protein sart-3 and tumor antigen peptides thereof
12/03/2009US20090297543 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
12/03/2009US20090297538 Neurotoxic oligomers
12/03/2009US20090297536 Compositions, kits, and methods for identification, assessment, prevention and therapy of cancer
12/03/2009US20090297528 Methods to identify compounds useful for the treatment of proliferative and differentiative disorders
12/03/2009US20090297525 Compositions, kits and methods for identification, assessment, prevention and therapy of cancer
12/03/2009US20090297520 Methods of using conjugated toxin peptide therapeutic agents
12/03/2009US20090297517 Methods for treating il-18 mediated disorders
12/03/2009US20090297516 Engineered lectins for viral inactivation
12/03/2009US20090297515 Use of Caspase-8 Inhibitors for Modulating Hematopoiesis
12/03/2009US20090297511 Prevention and treatment of amyloidogenic disease
12/03/2009US20090297510 Inhibition of calpain reduces allergic inflammation
12/03/2009US20090297509 Treatment of human tumors with radiation and inhibitors of growth factor receptor tyrosine kinases
12/03/2009US20090297508 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction
12/03/2009US20090297507 ADAM10 in Cancer Diagnosis, Detection and Treatment
12/03/2009US20090297504 Bcma polypeptides and uses thereof
12/03/2009US20090297502 Ccr2 antagonists for chronic organ transplantation rejection
12/03/2009US20090297498 Milk Fat Globule Epidermal Growth Factor-Factor VIII And Sepsis
12/03/2009US20090297497 Methods and compositions for treating nephrogenic diabetes and insipidus
12/03/2009US20090297496 Lysosomal Acid Lipase Therapy for NAFLD and Related Diseases
12/03/2009US20090297495 Hydrolases, nucleic acids encoding them and methods for improving paper strength
12/03/2009US20090297494 Diagnostic and treatment of a mental disorder
12/03/2009US20090297493 nanoporous particle with a retained target
12/03/2009US20090297492 Method for Improving Cognitive Performance
12/03/2009US20090297479 Dc-hil conjugates for treatment of t-cell disorders
1 ... 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 ... 3163